로라제팜을 함유한 Poly(D,L-lactic acid) 마이크로스피어 개발
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 최한곤 | - |
dc.contributor.author | 유봉규 | - |
dc.contributor.author | 이종달 | - |
dc.contributor.author | 김정애 | - |
dc.contributor.author | 권태협 | - |
dc.contributor.author | 우종수 | - |
dc.contributor.author | 용철순 | - |
dc.date.accessioned | 2021-06-23T22:06:57Z | - |
dc.date.available | 2021-06-23T22:06:57Z | - |
dc.date.created | 2021-02-01 | - |
dc.date.issued | 2006-06 | - |
dc.identifier.issn | 2093-5552 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/45223 | - |
dc.description.abstract | Poly(D,L-lacic acid)(PLA) microshperes containing loazepam were prepared by a solvent-emulsion evaporation method and their release patterns were investigated in vitro. Various batches of microspheres with different size and drug content were obtained by changing the ratio of lorazepam to PLA, PLA concentration in the dispersed phase and stirring rate. Rod-like lorazepam crystals on microsphere surface, which were released rapidly and could act as a loading dose, were observed with increasing drug content. The release rate was increased with increase in drug contents and decrease in the molecular weight of PLA. The release rate of lorazepam for long-acting injectable delivery system in vitro, which would aid in Predicting in vivo release Profile, could be controlled by properly optimizing various factors affecting characteristics of microspheres. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | 한국약제학회 | - |
dc.title | 로라제팜을 함유한 Poly(D,L-lactic acid) 마이크로스피어 개발 | - |
dc.title.alternative | Development of Poly(D,L-lactic acid) Microspheres Containing Lorazepam | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 최한곤 | - |
dc.identifier.doi | 10.4333/KPS.2006.36.3.175 | - |
dc.identifier.bibliographicCitation | Journal of Pharmaceutical Investigation, v.36, no.3, pp.175 - 184 | - |
dc.relation.isPartOf | Journal of Pharmaceutical Investigation | - |
dc.citation.title | Journal of Pharmaceutical Investigation | - |
dc.citation.volume | 36 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 175 | - |
dc.citation.endPage | 184 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001012175 | - |
dc.description.journalClass | 2 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Lorazepam | - |
dc.subject.keywordAuthor | Poly(D,L-lactic acid) | - |
dc.subject.keywordAuthor | Microspheres | - |
dc.subject.keywordAuthor | Injectable delivery system | - |
dc.identifier.url | https://www.koreascience.or.kr/article/JAKO200603042596732.page | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.